Related Experiment Videos
Cyclins and breast cancer.
Robert L Sutherland1, Elizabeth A Musgrove
1Cancer Research Program, Garvan Institute of Medical Research, St Vincent's Hospital, Darlinghurst, Sydney, Australia. r.sutherland@garvan.org.au
Journal of Mammary Gland Biology and Neoplasia
|April 15, 2004
Summary
D-type and E-type cyclins are crucial for normal cell cycle progression and breast cancer development. Overexpression of these cyclins contributes to mammary carcinoma and resistance to endocrine therapies.
Area of Science:
- Cell Biology
- Oncology
- Molecular Biology
Background:
- D-type and E-type cyclins regulate the G(1) to S phase transition.
- They are key in steroid and growth factor-induced mitogenesis in breast epithelial cells.
Purpose of the Study:
- Investigate the role of D-type and E-type cyclins in breast epithelial cell proliferation and mammary carcinogenesis.
- Determine the clinical significance of cyclin D1 and E1 overexpression in breast cancer.
Main Methods:
- Analysis of mammary gland development in cyclin D1-deficient mice.
- Assessment of mammary carcinoma development in response to oncogenes in cyclin D1 null mice.
- Examination of cyclin D1 and E1 expression in primary breast cancer tissues.
Main Results:
- Mammary epithelial cell-specific overexpression of cyclins D/E causes mammary carcinoma.
- Cyclin D1 deficiency arrests mammary gland development and confers resistance to oncogene-induced mammary tumors.
- Cyclin D1 and E1 are frequently overexpressed in breast cancer, correlating with adverse outcomes and endocrine therapy resistance.
Conclusions:
- Cyclin D1 and E1 play critical roles in mammary gland development and tumorigenesis.
- Overexpression of cyclins D1 and E1 is linked to poor prognosis and treatment resistance in breast cancer.
- Cyclin D1's role extends beyond cell cycle control to transcriptional regulation in breast cancer.